EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 4 June 2020

#WeWontRest in the fight against COVID-19

The collaborative search for a COVID-19 vaccine
04 June 2020 - Magdalena R. de Azero

As countries are gradually lifting the confinement measures, it is clear that new vaccines represent our best hope of... Read more

Building on the European Commission’s Roadmap for the EU Pharmaceutical Strategy
02 June 2020

EFPIA welcomes the European Commission’s recognition of the importance of the pharmaceutical sector in the Pharmaceutical... Read more

29052020 EFPIA statement in following the call with EU Commissioner Kyriakides (1)
29 May 2020

Today, together with industry sister associations EFPIA met with EU Health Commissioner Stella Kyriakides, other relevant... Read more

Videos

As we stay apart...
...the healthcare community is coming together to speed up the development of diagnostics and treatments to help... Read more

Europe’s COVID-19 battle: ensuring the supply of medicines to the patients that need them
EFPIA member companies are working around the clock to increase capacity and ensure supply of critical medicines to... Read more

Events

United in the search of a COVID-19 vaccine
09 June 2020 (Virtual event)

The first of a series of virtual events dedicated on COVID-19 vaccines and pandemic preparedness Read more

Diabetes and COVID-19: when two pandemics meet - Integrated care
11 June 2020 (Virtual event)

Rethinking health systems: integrated care and empowerment of primary care Read more

Diabetes and COVID-19: when two pandemics meet: digital health
15 June 2020 (Virtual event)

Engage, define, track, measure, improve: the potential of the digital transformation in diabetes care Read more

What we are reading

ABPI’s Sheuli Porkess on how COVID-19 could improve clinical trial conduct
On 28 May 2020 (pharmaphorum)

"Now, more than ever before, people are looking to research for answers, and I am very conscious that, in order to provide... Read more

Crucial step towards EC regulatory approval of IMI-funded J&J Ebola vaccine
On 29 May 2020 (IMI website)

Studies indicate that the vaccine regimen is well tolerated, with robust and durable immune responses to the Zaire ebolavirus... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu